trans-Fatty acids, insulin resistance/diabetes, and cardiovascular disease risk: should policy decisions be based on observational cohort studies, or should we be waiting for results from randomized placebo-controlled trials?

Metabolism. 2011 Jul;60(7):901-5. doi: 10.1016/j.metabol.2011.04.003.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Cardiovascular Diseases / diet therapy
  • Cardiovascular Diseases / etiology*
  • Cohort Studies
  • Diabetes Mellitus, Type 2 / complications
  • Diabetes Mellitus, Type 2 / diet therapy
  • Diabetes Mellitus, Type 2 / etiology*
  • Dietary Fats, Unsaturated / adverse effects*
  • Female
  • Health Policy*
  • Humans
  • Insulin Resistance*
  • Male
  • Randomized Controlled Trials as Topic
  • Trans Fatty Acids / adverse effects*

Substances

  • Dietary Fats, Unsaturated
  • Trans Fatty Acids